Select one of the options below:
Social impacts of biomedical research, including historical perspectives and ongoing areas of concern. Students will be challenged to develop an action plan to address a major issue within their chosen field.
Written consent of instructor.
Synchronous only – no recordings for this online class.
Amanda received her B.A. in Botany/Microbiology and Politics & Government from Ohio Wesleyan University in 2008, and her PhD in Molecular Medicine from George Washington University in 2013. Working with Dr. David Mendelowitz, she designed the first animal model of perinatal exposure to the air pollutant sulfur dioxide and identified the mechanism by which it produces tachycardia and cardiovascular disease. In July 2013, Amanda joined Dr. Stanley Prusiner’s laboratory at UCSF as a postdoctoral fellow, where she developed cellular assays for tau and alpha-synuclein prions, which she employed to investigate the role of prion strains in neurodegenerative disease. Amanda joined the Biology faculty at UMass Amherst as an Assistant Professor in September 2019, where her independent lab focused on tau and alpha-synuclein strain biology and pathogenesis. In August 2023, Amanda joined the Microbiology, Immunology, and Pathology Department at Colorado State University as an Associate Professor, where her lab continues to investigate the agent and host factors underlying disease pathogenesis in neurodegenerative disease.
Elizabeth.Hemming-Schroeder@colostate.edu
Dr. Hemming-Schroeder is an Assistant Professor and member of the Center for Vector-borne Infectious Diseases. Dr. Hemming-Schroeder's research training includes the study of malaria, a disease that affects nearly half of the world's population, as well as tick-borne diseases in the United States. Her research primarily uses methods in molecular biology, population genetics, and bioinformatics to study vector-borne disease ecology and epidemiology. She is broadly interested in how ecological factors, environmental modifications, and public health interventions impact pathogen and vector population dynamics and how genetic and epidemiological information on pathogens and vectors can be used to improve infectious disease control and elimination.